In-vivo Methods for Assessing Placental Development and Function (STTR) [R41/R42]

The summary for the In-vivo Methods for Assessing Placental Development and Function (STTR) [R41/R42] grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
In-vivo Methods for Assessing Placental Development and Function (STTR) [R41/R42]: This Funding Opportunity Announcement (FOA) invites grant applications for research in for the development of safe, real-time, non-invasive (or minimally invasive), in vivo methods to assess the development and function of the human placenta.
Federal Grant Title: In-vivo Methods for Assessing Placental Development and Function (STTR) [R41/R42]
Federal Agency Name: National Institutes of Health
Grant Categories: Health Income Security and Social Services
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-HD-15-019
Type of Funding: Grant
CFDA Numbers: 93.286, 93.865
CFDA Descriptions: Discovery and Applied Research for Technological Innovations to Improve Human Health; Child Health and Human Development Extramural Research
Current Application Deadline: Sep 15, 2014
Original Application Deadline: Sep 15, 2014
Posted Date: Jul 11, 2014
Creation Date: Jul 11, 2014
Archive Date: Oct 16, 2014
Total Program Funding: $2,000,000
Maximum Federal Grant Award: $2,000,000
Minimum Federal Grant Award: none
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Small businesses
Additional Information on Eligibility
Other Eligible Applicants include the following:
Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/rfa-files/RFA-HD-15-019.html
Grant Announcement Contact
NIH OER Webmaster [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

National Institutes of Health 301-496-3405
Similar Government Grants
New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Opt...
Enhancing Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) at Historic...
Understanding and Mitigating Health Disparities experienced by People with Disabilities ca...
National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Op...
Research on Bioethical Issues Related to Bionic and Robotic Device Development and Transla...
Exploratory Grants (P20) for NIBIB Quantum Projects
Nibib Research Supplements to Promote Clinical Resident Research Experiences
Innovation in Molecular Imaging Probes
More Grants from the National Institutes of Health
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...
Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com